Multi-Chem Limited (SGX:AWZ)
Singapore
· Delayed Price · Currency is SGD 3.850
+0.050 (1.32%)
Apr 28, 2026, 5:04 PM SGT
Multi-Chem Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 653.93 | 683.68 | 658.42 | 616.98 | 603.64 | Upgrade
|
| Revenue Growth (YoY) | -4.35% | 3.84% | 6.72% | 2.21% | 25.83% | Upgrade
|
| Cost of Revenue | 564.29 | 586.21 | 563.63 | 529.97 | 518.13 | Upgrade
|
| Gross Profit | 89.64 | 97.48 | 94.79 | 87.01 | 85.51 | Upgrade
|
| Selling, General & Admin | 62.05 | 63.55 | 62.2 | 64.35 | 54.77 | Upgrade
|
| Operating Expenses | 62.23 | 64.46 | 62.66 | 64.12 | 54.22 | Upgrade
|
| Operating Income | 27.41 | 33.02 | 32.14 | 22.89 | 31.29 | Upgrade
|
| Interest Expense | -3.63 | -1.57 | -0.84 | -0.46 | -0.33 | Upgrade
|
| Interest & Investment Income | 6.47 | 4.7 | 2.73 | 1.02 | 0.6 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.69 | 0.22 | 0.16 | - | 1.48 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.82 | 1.94 | 1.91 | 1.46 | 0.9 | Upgrade
|
| EBT Excluding Unusual Items | 32.76 | 38.31 | 36.09 | 24.91 | 33.94 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.14 | 0.15 | 0.15 | 0.16 | 0.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | 0.37 | - | 0.16 | 0.24 | Upgrade
|
| Asset Writedown | -0.01 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.01 | - | 0.29 | 0.38 | 1.55 | Upgrade
|
| Pretax Income | 32.97 | 38.82 | 36.53 | 25.6 | 35.95 | Upgrade
|
| Income Tax Expense | 6.53 | 8 | 9.41 | 5.6 | 8.62 | Upgrade
|
| Earnings From Continuing Operations | 26.44 | 30.82 | 27.12 | 20 | 27.33 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -2.38 | Upgrade
|
| Net Income | 26.44 | 30.82 | 27.12 | 20 | 24.96 | Upgrade
|
| Net Income to Common | 26.44 | 30.82 | 27.12 | 20 | 24.96 | Upgrade
|
| Net Income Growth | -14.21% | 13.62% | 35.63% | -19.88% | 40.41% | Upgrade
|
| Shares Outstanding (Basic) | 90 | 90 | 90 | 90 | 90 | Upgrade
|
| Shares Outstanding (Diluted) | 90 | 90 | 90 | 90 | 90 | Upgrade
|
| EPS (Basic) | 0.29 | 0.34 | 0.30 | 0.22 | 0.28 | Upgrade
|
| EPS (Diluted) | 0.29 | 0.34 | 0.30 | 0.22 | 0.28 | Upgrade
|
| EPS Growth | -14.21% | 13.64% | 35.61% | -19.88% | 40.41% | Upgrade
|
| Free Cash Flow | 45.42 | 36.12 | 24.84 | 11.27 | 26.21 | Upgrade
|
| Free Cash Flow Per Share | 0.50 | 0.40 | 0.28 | 0.13 | 0.29 | Upgrade
|
| Dividend Per Share | 0.311 | 0.253 | 0.243 | 0.177 | 0.111 | Upgrade
|
| Dividend Growth | 22.93% | 4.12% | 37.29% | 59.46% | 68.18% | Upgrade
|
| Gross Margin | 13.71% | 14.26% | 14.40% | 14.10% | 14.17% | Upgrade
|
| Operating Margin | 4.19% | 4.83% | 4.88% | 3.71% | 5.18% | Upgrade
|
| Profit Margin | 4.04% | 4.51% | 4.12% | 3.24% | 4.13% | Upgrade
|
| Free Cash Flow Margin | 6.94% | 5.28% | 3.77% | 1.83% | 4.34% | Upgrade
|
| EBITDA | 28.14 | 33.9 | 33.3 | 24.22 | 32.6 | Upgrade
|
| EBITDA Margin | 4.30% | 4.96% | 5.06% | 3.92% | 5.40% | Upgrade
|
| D&A For EBITDA | 0.73 | 0.88 | 1.16 | 1.32 | 1.31 | Upgrade
|
| EBIT | 27.41 | 33.02 | 32.14 | 22.89 | 31.29 | Upgrade
|
| EBIT Margin | 4.19% | 4.83% | 4.88% | 3.71% | 5.18% | Upgrade
|
| Effective Tax Rate | 19.80% | 20.61% | 25.75% | 21.88% | 23.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.